4,4′-Bis(2-Bromoacetyl)biphenyl CAS 4072-67-7 Daclatasvir Dihydrochloride Bohloeki ba Mahareng >98.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. ke moetsi ea ka sehloohong oa 4,4'-Bis(2-Bromoacetyl) biphenyl (CAS: 4072-67-7) e nang le boleng bo phahameng.Ruifu Chemical e ka fana ka lits'ebeletso tsa lefats'e ka bophara, theko ea tlholisano, litšebeletso tse ntle haholo, tse nyane le tse ngata tse fumanehang.Reka 4,4'-Bis(2-Bromoacetyl)biphenyl,Please contact: alvin@ruifuchem.com
| Lebitso la Lik'hemik'hale | 4,4'-Bis(2-Bromoacetyl)biphenyl |
| Litlhaloso tse tšoanang | 4,4'-Bis(Bromoacetyl)biphenyl;1,1'-[1,1'-Biphenyl]-4,4'-diylbis[2-Bromoethan-1-one];Tšilafalo ea Daclatasvir 7 |
| Boemo ba Setoko | Ka Stock, Tlhahiso ea Khoebo |
| Nomoro ea CAS | 4072-67-7 |
| Foromo ea limolek'hule | C16H12Br2O2 |
| Boima ba Molek'hule | 396.07 g/mol |
| Melting Point | 226.0~227.0℃ |
| Botenya | 1.622±0.06 g/cm3 |
| COA & MSDS | E fumaneha |
| Tšimoloho | Shanghai, China |
| Sehlopha | Bohareng ba Daclatasvir Dihydrochloride (CAS: 1009119-65-6) |
| Brand | Ruifu Chemical |
| Lintho | Litlhaloso | Liphetho |
| Ponahalo | Tiileng | Tiileng |
| Mokhoa oa Bohloeki / Analysis | >98.0% (HPLC) | 98.5% |
| Infrared Spectrum | E tsamaellanang le Sebopeho | E lumellana |
| 1H NMR Spectrum | E tsamaellanang le Sebopeho | E lumellana |
| Qetello | Sehlahisoa se lekoa 'me se lumellana le litlhaloso tse fanoeng | |
| Kopo | Bohareng ba Daclatasvir Dihydrochloride (CAS: 1009119-65-6) | |
Sephutheloana:Botlolo ea Fluorinated, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho latela tlhoko ea moreki.
Boemo ba polokelo:Boloka setshelo se koetsoe ka thata 'me u se boloke sebakeng sa polokelo se pholileng, se omeletseng le se nang le moea o motle hole le lintho tse sa lumellaneng.Sireletsa leseli le mongobo.
Ho tsamaisa ka sekepe:Tsamaisa lefatšeng ka bophara ka sefofane, ka FedEx / DHL Express.Fana ka thomello e potlakileng le e tšepahalang.
Mokhoa oa ho Reka?Ka kopo ikopanyeDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Phihlelo ea Lilemo Tse 15?Re na le boiphihlelo ba lilemo tse fetang 15 ho etsa le ho romella kantle ho naha mefuta e mengata e fapaneng ea li-intermediate tsa boleng bo holimo tsa meriana kapa lik'hemik'hale tse ntle.
Limmaraka tse ka Sehloohong?Rekisetsa 'maraka oa lapeng, Amerika Leboea, Europe, India, Korea, Japane, Australia, joalo-joalo.
Melemo?Boleng bo phahameng, theko e theko e tlaase, lits'ebeletso tsa litsebi le ts'ehetso ea tekheniki, phano e potlakileng.
BolengTiisetso?Tsamaiso e thata ea taolo ea boleng.Lisebelisoa tsa profeshenale bakeng sa tlhahlobo li kenyelletsa NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, joalo-joalo.
Mehlala?Lihlahisoa tse ngata li fana ka mehlala ea mahala bakeng sa tlhahlobo ea boleng, litšenyehelo tsa ho tsamaisa thepa li lokela ho lefshoa ke bareki.
Feme Audit?Ho amoheloa ha fektheri.Ke kopa o etse kopano esale pele.
MOQ?Ha ho MOQ.Taelo e nyenyane e amoheleha.
Nako ea thomello? Haeba ka har'a setoko, ho netefalitsoe hore ho tsamaisoa ka matsatsi a mararo.
Lipalangoang?Ka Express (FedEx, DHL), ka Moea, ka Leoatle.
Litokomane?Ka mor'a tšebeletso ea thekiso: COA, MOA, ROS, MSDS, joalo-joalo e ka fanoa.
Custom Synthesis?E ka fana ka lits'ebeletso tsa tloaelo tsa ho kopanya ho lekana hantle litlhoko tsa hau tsa lipatlisiso.
Litefiso Melao?Invoice ea Proforma e tla romelloa pele kamora netefatso ea odara, e kenyellelitseng tlhahisoleseling ea rona ea banka.Tefo ka T/T (Telex Transfer), PayPal, Western Union, joalo-joalo.
4,4'-Bis (2-Bromoacetyl) biphenyl (CAS: 4072-67-7) ke bohareng ba Daclatasvir Dihydrochloride (CAS: 1009119-65-6).
Daclatasvir Dihydrochloride (Daklinza) ke inhibitor ea kokoana-hloko ea hepatitis C (HCV) NS5A e thusang ho phekola genotype 3 tšoaetso e sa foleng ea lefu la sebete la C.
Ka la 24 Phupu 2015, FDA e amohetse sethethefatsi se sa foleng sa lefu la sebete sa C (Bristol-Myers Squibb) bakeng sa ho bapatsa.
Ts'ebetso ea tumello ea FDA ea Daklinza (Bristol-Myers Squibb) e se e fetohile.E kile ea hanoa ke FDA, empa qetellong ea amoheloa bohareng ba 2015.FDA e amohetse motsoako oa Daklinza le Sofosbuvir bakeng sa kalafo ea bakuli ba mofuta oa 3 oa lefu la sebete la mofuta oa C.
Ha e le hantle, pele ho tumello ea FDA, Daklinza e ne e amohetsoe bakeng sa ho bapatsa Japane, European Union le Korea Boroa le linaheng tse ling.Ka 2014, lekala la bophelo la Japane le ile la amohela kopo ea Daklinza le Asunaprevir (Sunvepra) bakeng sa phekolo ea tšoaetso ea genotype 1.European Union e boetse e amohetse Daclatasvir hore e sebelisoe hammoho le lithethefatsi tse ling kalafong ea HCV genotypes 1, 2, 3 le 4 ka 2014. Daclatasvir ke NS5A complex inhibitor ea pele e amohetsoeng ke European Union (EU).Ha e sebelisoa hammoho le lithethefatsi tse ling, ha e bapisoa le motsoako oa kalafo oa interferon le ribavirin, e nkang libeke tse 48, e na le nako e khuts'oane ea kalafo (libeke tse 12 kapa libeke tse 24).
Daclathavir monotherapy ha e khothalletsoe, protocol ea morao-rao e tloaelehileng ke phekolo e kopantsoeng ea Dacastavir+ Sofosbuvir, e khetholloang ka katleho e ntle, SVR e phahameng, litla-morao tse nyenyane le potoloho ea phekolo e khutsufalitsoeng ho feta mekhoa e meng.
